Chemoinformaics analysis of Panaquinquecol 7
| Molecular Weight | 276.376 | nRot | 9 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 6 |
| Exact Molecular Weight | 276.173 | nRing | 1 |
| Solubility: LogS | -4.084 | nHRing | 1 |
| Solubility: LogP | 3.964 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 46.799 |
| nHD | 1 | BPOL | 26.681 |
| QED | 0.304 |
| Synth | 3.985 |
| Natural Product Likeliness | 2.089 |
| NR-PPAR-gamma | 0.712 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.284 |
| Pgp-sub | 0.001 |
| HIA | 0.017 |
| CACO-2 | -4.254 |
| MDCK | 0.0000309 |
| BBB | 0.01 |
| PPB | 0.984776 |
| VDSS | 1.364 |
| FU | 0.0118083 |
| CYP1A2-inh | 0.147 |
| CYP1A2-sub | 0.459 |
| CYP2c19-inh | 0.813 |
| CYP2c19-sub | 0.482 |
| CYP2c9-inh | 0.754 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.501 |
| CYP3a4-sub | 0.081 |
| CL | 9.418 |
| T12 | 0.36 |
| hERG | 0.004 |
| Ames | 0.433 |
| ROA | 0.234 |
| SkinSen | 0.952 |
| Carcinogencity | 0.706 |
| EI | 0.979 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.916 |
| Antiviral | Yes |
| Prediction | 0.771191 |